AZZONI, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 1.543
EU - Europa 1.292
AS - Asia 826
AF - Africa 11
OC - Oceania 2
Totale 3.674
Nazione #
US - Stati Uniti d'America 1.513
CN - Cina 514
IE - Irlanda 316
SE - Svezia 255
SG - Singapore 235
FI - Finlandia 202
IT - Italia 196
UA - Ucraina 98
DE - Germania 91
TR - Turchia 43
AT - Austria 39
CA - Canada 30
GB - Regno Unito 25
FR - Francia 24
IN - India 22
BE - Belgio 21
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 7
IR - Iran 5
NL - Olanda 5
RU - Federazione Russa 4
HK - Hong Kong 3
LT - Lituania 3
AU - Australia 2
DK - Danimarca 2
VN - Vietnam 2
ES - Italia 1
GR - Grecia 1
KZ - Kazakistan 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.674
Città #
Chandler 357
Dublin 316
Singapore 198
Jacksonville 110
Dearborn 105
Ashburn 101
Ann Arbor 92
Beijing 81
Shanghai 77
Boardman 75
Parma 74
Nanjing 70
Princeton 48
New York 45
Izmir 42
Vienna 39
Jinan 36
Wilmington 30
San Mateo 27
Shenyang 26
Helsinki 23
Tianjin 22
Toronto 20
Nanchang 19
Bremen 18
Seattle 18
Changsha 17
Hebei 17
Los Angeles 17
Hefei 16
Marseille 16
Woodbridge 16
Brussels 15
Bologna 14
Kunming 14
Chicago 12
Pune 12
Santa Clara 12
Des Moines 11
Abidjan 10
Guangzhou 10
Hangzhou 10
Rio Saliceto 8
Zhengzhou 8
Haikou 7
Ningbo 7
Ottawa 7
Jiaxing 6
Louvain-la-Neuve 6
Munich 6
Norwalk 6
Taiyuan 6
Dallas 5
Lanzhou 5
Taizhou 5
Auburn Hills 4
Borås 4
Busseto 4
Falls Church 4
Fremont 4
Fuzhou 4
London 4
Andover 3
Bari 3
Leawood 3
Massarosa 3
Modena 3
Pavia 3
Rockville 3
Sacramento 3
Assago 2
Brno 2
Candiac 2
Chongqing 2
Dong Ket 2
Forlì 2
Hong Kong 2
Houston 2
Mestre 2
Milan 2
Minerbio 2
Mola Di Bari 2
Redwood City 2
Reggio Emilia 2
Selvazzano Dentro 2
Vanløse 2
Xian 2
Adelaide 1
Almaty 1
Amsterdam 1
Antwerp 1
Arcole 1
Bangalore 1
Baotou 1
Cambridge 1
Carlentini 1
Casalgrande 1
Casamarciano 1
Chengdu 1
Chiayi County 1
Totale 2.469
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 113
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 98
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 98
Human Papilloma Virus (HPV) status, P16INK4a and p53 overexpression in epithelial malignant and borderline ovarian neoplasms 97
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 96
Classification of gastric endocrine cells at the light and electron microscopical levels 94
Atrophic body gastriris patients with enterochromaffin-like cell dysplasia are at increased risk for development of type I gastric carcinoid 90
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 88
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 87
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 86
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 84
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 84
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 84
Notch expression and bevacizumab efficacy in colorectal cancer patients 80
Histological subtype analysis of colon cancer: a population-based study. Different sides and different diseases. 79
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 78
Pleomorph poorly differentiated endocrine carcinoma of the rectum 77
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 76
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 75
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 75
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 75
Metaplastic papillary tumour of the salpinx: report of a case with microsatellite analysis 74
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 71
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 70
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 69
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 69
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 68
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 68
Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms. 67
Primary Squamous Cell Carcinoma of the Endometrium Unrelated to Human Papilloma Virus: A Molecular Study 67
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer 66
Microsatellite instability in colorectal cancer 66
Pancreatic Polypeptide-related tumors 65
Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy 65
Monitoring cfDNA in plasma and in other liquid biopsies of advanced EGFR mutated NSCLC patients: A pilot study and a review of the literature 64
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 63
ANASTOMOTIC RECURRENCE OF COLON CANCER: GENETIC ANALYSIS CHALLANGES THE WIDELY HELD THEORIES OF CANCEROUS CELLS’ INTRALUMINAL IMPLANTATION AND METACHRONOUS CARCINOGENESIS 63
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 63
P16INK4a overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas 62
Different patterns of 11q allelic losses in digestive endocrine tumors 62
Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients 60
Surgical treatment of multiple sporadic colorectal carcinoma 59
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 58
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 55
Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features 54
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 51
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 48
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 48
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. 46
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 45
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 34
Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study 34
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 30
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study 24
Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1. 16
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups 8
Totale 3.746
Categoria #
all - tutte 14.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.863


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020416 0 0 0 0 45 87 63 12 38 127 12 32
2020/2021245 5 24 24 26 32 8 25 10 48 7 32 4
2021/2022279 6 1 4 18 13 8 42 24 16 17 34 96
2022/20231.232 106 155 66 96 101 146 12 85 393 14 43 15
2023/2024435 27 29 9 7 30 121 42 41 17 24 25 63
2024/2025391 36 65 97 104 89 0 0 0 0 0 0 0
Totale 3.746